{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:09:51Z","timestamp":1758042591265,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bone.2020.115821","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T06:27:56Z","timestamp":1608359276000},"page":"115821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Morphological, functional, and molecular assessment of breast cancer bone metastases by experimental ultrasound techniques compared with magnetic resonance imaging and histological analysis"],"prefix":"10.1016","volume":"144","author":[{"given":"Henrik","family":"Heinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Seyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Popp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Bozec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Uder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Ellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"B\u00e4uerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bone.2020.115821_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.bone.2020.115821_bb0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1148\/radiol.2018181927","article-title":"MRI brain signal intensity and relaxation times in individuals with prior exposure to gadobutrol","volume":"290","author":"Saake","year":"2019","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.bone.2020.115821_bb0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jot.2015.07.004","article-title":"Multimodal imaging of bone metastases: from preclinical to clinical applications","volume":"3","author":"Ellmann","year":"2015","journal-title":"J. Orthop. Translat."},{"issue":"1","key":"10.1016\/j.bone.2020.115821_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cpet.2018.08.003","article-title":"Hybrid imaging (PET-computed tomography\/PET-MR imaging) of bone metastases","volume":"14","author":"Schmidkonz","year":"2019","journal-title":"PET clinics"},{"issue":"4","key":"10.1016\/j.bone.2020.115821_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/138920112799436285","article-title":"Monitoring molecular, functional and morphologic aspects of bone metastases using non-invasive imaging","volume":"13","author":"B\u00e4uerle","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.bone.2020.115821_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2214\/ajr.138.1.91","article-title":"Radiographic evaluation of rib fractures","volume":"138","author":"DeLuca","year":"1982","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.bone.2020.115821_bb0035","doi-asserted-by":"crossref","unstructured":"K. S. Lee, A. A. de Smet, G. Liu et al., \u201cHigh resolution ultrasound features of prostatic rib metastasis: A prospective feasibility study with implication in the high-risk prostate cancer patient,\u201d Urologic oncology, vol. 32, no. 1, 24.e7\u201311, 2014 doi:https:\/\/doi.org\/10.1016\/j.urolonc.2012.08.014.","DOI":"10.1016\/j.urolonc.2012.08.014"},{"issue":"3","key":"10.1016\/j.bone.2020.115821_bb0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2214\/ajr.184.3.01840969","article-title":"High-resolution sonography of the rib: can fracture and metastasis be differentiated?","volume":"184","author":"Paik","year":"2005","journal-title":"AJR Am. J. Roentgenol."},{"year":"2020","series-title":"Ultrasound-guided focused ultrasound treatment for painful bone metastases: a pilot study","author":"Drost","key":"10.1016\/j.bone.2020.115821_bb0045"},{"issue":"12","key":"10.1016\/j.bone.2020.115821_bb0050","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1158\/1078-0432.CCR-09-2932","article-title":"Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study","volume":"16","author":"B\u00e4uerle","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bone.2020.115821_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jvs.2016.12.133","article-title":"Vascular applications of contrast-enhanced ultrasound imaging","volume":"66","author":"Mehta","year":"2017","journal-title":"J. Vasc. Surg."},{"issue":"5","key":"10.1016\/j.bone.2020.115821_bb0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/092986709787458470","article-title":"Functional and molecular ultrasound imaging: concepts and contrast agents","volume":"16","author":"Kiessling","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bone.2020.115821_bb0065","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00261-017-1329-7","article-title":"Contrast-enhanced ultrasound (CEUS) of the abdominal vasculature","volume":"43","author":"Rafailidis","year":"2018","journal-title":"Abdom. Radiol. (NY)"},{"key":"10.1016\/j.bone.2020.115821_bb0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fendo.2015.00159","article-title":"The emerging regulation of VEGFR-2 in triple-negative breast cancer","volume":"6","author":"Zhu","year":"2015","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2020.115821_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/RLI.0000000000000362","article-title":"First-in-human ultrasound molecular imaging with a VEGFR2-specific ultrasound molecular contrast agent (BR55) in prostate cancer: a safety and feasibility pilot study","volume":"52","author":"Smeenge","year":"2017","journal-title":"Investig. Radiol."},{"issue":"19","key":"10.1016\/j.bone.2020.115821_bb0080","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1200\/JCO.2016.70.8594","article-title":"Ultrasound molecular imaging with BR55 in patients with breast and ovarian lesions: first-in-human results","volume":"35","author":"Willmann","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bone.2020.115821_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.20840","article-title":"Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein","volume":"115","author":"B\u00e4uerle","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bone.2020.115821_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10278-004-1014-6","article-title":"OsiriX: an open-source software for navigating in multidimensional DICOM images","volume":"17","author":"Rosset","year":"2004","journal-title":"J. Digit. Imaging"},{"issue":"3","key":"10.1016\/j.bone.2020.115821_bb0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","article-title":"Adaptive linear step-up procedures that control the false discovery rate","volume":"93","author":"Benjamini","year":"2006","journal-title":"Biometrika"},{"issue":"6","key":"10.1016\/j.bone.2020.115821_bb0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/bjs.9463","article-title":"Comparison of three ultrasound methods of measuring the diameter of the abdominal aorta","volume":"101","author":"G\u00fcrtelschmid","year":"2014","journal-title":"Br. J. Surg."},{"issue":"7","key":"10.1016\/j.bone.2020.115821_bb0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/RLI.0b013e31824f635a","article-title":"Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases","volume":"47","author":"Merz","year":"2012","journal-title":"Investig. Radiol."},{"issue":"10","key":"10.1016\/j.bone.2020.115821_bb0110","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00330-009-1443-1","article-title":"Imaging response to systemic therapy for bone metastases","volume":"19","author":"B\u00e4uerle","year":"2009","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.bone.2020.115821_bb0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bone.2018.11.008","article-title":"Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET\/CT and MRI parameters to a model-averaged neural network","volume":"120","author":"Ellmann","year":"2019","journal-title":"Bone"},{"year":"2019","series-title":"Optimized anti-prostate-specific membrane antigen single-chain variable fragment-loaded nanobubbles as a novel targeted ultrasound contrast agent for the diagnosis of prostate cancer","author":"Ding","key":"10.1016\/j.bone.2020.115821_bb0120"},{"issue":"1","key":"10.1016\/j.bone.2020.115821_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1078-0432.CCR-06-1313","article-title":"Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature","volume":"13","author":"Korpanty","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2020.115821_bb0130","doi-asserted-by":"crossref","unstructured":"R. S. Eschbach, D.-A. Clevert, H. Hirner-Eppeneder et al., \u201cContrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring regorafenib therapy effects in experimental colorectal adenocarcinomas in rats with DCE-MRI and immunohistochemical validation,\u201d PLoS ONE, vol. 12, no. 1, e0169323, 2017 doi:https:\/\/doi.org\/10.1371\/journal.pone.0169323.","DOI":"10.1371\/journal.pone.0169323"},{"issue":"1","key":"10.1016\/j.bone.2020.115821_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11307-014-0764-x","article-title":"Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma","volume":"17","author":"Baron Toaldo","year":"2015","journal-title":"Mol. Imaging Biol."},{"issue":"22","key":"10.1016\/j.bone.2020.115821_bb0140","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-17-1225","article-title":"Bone-induced expression of integrin \u03b23 enables targeted nanotherapy of breast cancer metastases","volume":"77","author":"Ross","year":"2017","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bone.2020.115821_bb0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12149-019-01400-6","article-title":"PSMA SPECT\/CT with 99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels","volume":"33","author":"Schmidkonz","year":"2019","journal-title":"Ann. Nucl. Med."},{"issue":"10","key":"10.1016\/j.bone.2020.115821_bb0150","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/RLI.0000000000000661","article-title":"Ultrasound molecular imaging with BR55, a predictive tool of antiangiogenic treatment efficacy in a chemo-induced mammary tumor model","volume":"55","author":"Helbert","year":"2020","journal-title":"Investig. Radiol."},{"issue":"12","key":"10.1016\/j.bone.2020.115821_bb0155","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1111\/cas.14208","article-title":"Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer","volume":"110","author":"Lu","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bone.2020.115821_bb0160","doi-asserted-by":"crossref","unstructured":"S. H. Park, M. R. Eber, and Y. Shiozawa, \u201cModels of prostate cancer bone metastasis,\u201d Methods in molecular biology (Clifton, N.J.), vol. 1914, pp. 295\u2013308, 2019 doi:https:\/\/doi.org\/10.1007\/978-1-4939-8997-3_16.","DOI":"10.1007\/978-1-4939-8997-3_16"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220306098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220306098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:51:49Z","timestamp":1757613109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220306098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"alternative-id":["S8756328220306098"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115821","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphological, functional, and molecular assessment of breast cancer bone metastases by experimental ultrasound techniques compared with magnetic resonance imaging and histological analysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115821"}}